RBC calls SFM an appealing entry point. Sales growth and new products could drive fresh returns.
Canadian defense names are crushing the TSX. With spending set to hit 2% of GDP, the rally could just be starting.
Our three Sunday stories include frozen assets ready to defrost, an AI titan that’s just getting warmed up, and a humble PC maker turning into a server king.
Our 5 top tweets of the week include Ferrari's sales, gold's big weeks, and Polymarket front-running the Nobel Prize announcement.
Here’s everything you might have missed last week on Wall Street, and everything to watch in the week ahead.
With margins holding up and international growth steady, Weatherford could be a value play worth another look.
DraftKings gets a fresh Buy from Berenberg. Analysts say the pullback may be your best entry in months.
CG Oncology's lead therapy could redefine bladder cancer care. Guggenheim’s Buy call points to a promising path to FDA approval.
Astera Labs open-standard tech could make it one of AI’s top hardware plays.
Klarna's IPO pop cooled off, but Wall Street’s heating up. UBS, Deutsche, and JPMorgan all see major upside ahead.
$TOU.TSX and $CNQ.TSX trade at just ~11x earnings. Energy + dividends = a pick-and-shovel play on AI’s growth?
Our three Sunday stories include a hot stock poised to keep surging, a mega-rally that may have gone too far, and what may well be the last value sector left.
Our 5 top tweets of the week include Sora's insane realism and three charts that highlight how the economy is doing.
1 Trading Idea. 1 Email. Every Day.
Unlock Our Latest Research Report
Join Street Sheet Research Today
